• Something wrong with this record ?

New approach of validation using internal normalization technique for quantification of related substances in raw material, intermediates and pharmaceutical substances by HPLC

M. Douša, P. Gibala, T. Pekárek,

. 2015 ; 114 (-) : 133-8. [pub] 20150522

Language English Country England, Great Britain

Document type Journal Article, Validation Study

Internal normalization (IN) serves as a quantitative tool in gas chromatography. Nevertheless, its utilization in liquid chromatography is not widely employed, as several requirements need to be taken into account. However, IN can be used in case of relative amounts estimation when the absolute concentration is not the crucial factor. This suits very well in pharmaceutical analysis when the relative amount of active pharmaceutical ingredient (API) impurities is to be estimated with a limited knowledge of statistics, such as t-test and linear regression. The determination of three prasugrel impurities in the real sample by means of IN and the comparison of these results with external standard calibration was presented. The IN method was validated by test of population means and variances agreement and the agreement of external calibration and IN was performed by Student t-test. The influence of impurities concentration above and below is also discussed as well as the validation parameters, LOD and LOQ. It was found that the results achieved by external calibration and IN are statistically the same and, therefore, IN is a proper method for relative amount estimation of API impurities.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16020716
003      
CZ-PrNML
005      
20160729105209.0
007      
ta
008      
160722s2015 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.jpba.2015.05.015 $2 doi
024    7_
$a 10.1016/j.jpba.2015.05.015 $2 doi
035    __
$a (PubMed)26037162
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Douša, Michal $u Zentiva, k.s. Praha, a Sanofi Company, U Kabelovny 130, 102 37 Praha 10, Czech Republic. Electronic address: michal.dousa@seznam.cz.
245    10
$a New approach of validation using internal normalization technique for quantification of related substances in raw material, intermediates and pharmaceutical substances by HPLC / $c M. Douša, P. Gibala, T. Pekárek,
520    9_
$a Internal normalization (IN) serves as a quantitative tool in gas chromatography. Nevertheless, its utilization in liquid chromatography is not widely employed, as several requirements need to be taken into account. However, IN can be used in case of relative amounts estimation when the absolute concentration is not the crucial factor. This suits very well in pharmaceutical analysis when the relative amount of active pharmaceutical ingredient (API) impurities is to be estimated with a limited knowledge of statistics, such as t-test and linear regression. The determination of three prasugrel impurities in the real sample by means of IN and the comparison of these results with external standard calibration was presented. The IN method was validated by test of population means and variances agreement and the agreement of external calibration and IN was performed by Student t-test. The influence of impurities concentration above and below is also discussed as well as the validation parameters, LOD and LOQ. It was found that the results achieved by external calibration and IN are statistically the same and, therefore, IN is a proper method for relative amount estimation of API impurities.
650    _2
$a kalibrace $7 D002138
650    _2
$a farmaceutická chemie $x normy $7 D002626
650    _2
$a vysokoúčinná kapalinová chromatografie $x metody $x normy $7 D002851
650    _2
$a koncentrace vodíkových iontů $7 D006863
650    _2
$a limita detekce $7 D057230
650    _2
$a léčivé přípravky $x chemie $7 D004364
650    _2
$a prasugrel hydrochlorid $x analýza $7 D000068799
650    _2
$a reprodukovatelnost výsledků $7 D015203
655    _2
$a časopisecké články $7 D016428
655    _2
$a validační studie $7 D023361
700    1_
$a Gibala, Petr $u Zentiva, k.s. Praha, a Sanofi Company, U Kabelovny 130, 102 37 Praha 10, Czech Republic.
700    1_
$a Pekárek, Tomáš $u Zentiva, k.s. Praha, a Sanofi Company, U Kabelovny 130, 102 37 Praha 10, Czech Republic.
773    0_
$w MED00002894 $t Journal of pharmaceutical and biomedical analysis $x 1873-264X $g Roč. 114, č. - (2015), s. 133-8
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26037162 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20160722 $b ABA008
991    __
$a 20160729105432 $b ABA008
999    __
$a ok $b bmc $g 1155386 $s 945244
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 114 $c - $d 133-8 $e 20150522 $i 1873-264X $m Journal of pharmaceutical and biomedical analysis $n J Pharm Biomed Anal $x MED00002894
LZP    __
$a Pubmed-20160722

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...